Literature DB >> 26306530

Antioxidant Capacity of Poly(Ethylene Glycol) (PEG) as Protection Mechanism Against Hydrogen Peroxide Inactivation of Peroxidases.

Karla Juarez-Moreno1, Marcela Ayala2, Rafael Vazquez-Duhalt3.   

Abstract

The ability of poly(ethylene glycol) (PEG) to protect enzymatic peroxidase activity was determined for horseradish peroxidase (HRP), versatile peroxidase (VP), commercial Coprinus peroxidase (BP), and chloroperoxidase (CPO). The operational stability measured as the total turnover number was determined for the four peroxidases. The presence of PEG significantly increased the operational stability of VP and HRP up to 123 and 195%, respectively, and dramatically increased the total turnover number of BP up to 597%. Chloroperoxidase was not protected by PEG, which may be due to the different oxidation mechanism, in which the oxidation is mediated by hypochlorous ion instead of free radicals as in the other peroxidases. The presence of PEG does not protect the enzyme when incubated only in the presence of H2O2 without reducing substrate. The catalytic constants (k cat) are insensitive to the presence of PEG, suggesting that the protection mechanism is not due to a competition between the PEG and the substrate as electron donors. On the other hand, PEG showed to have a significant antioxidant capacity. Thus, we conclude that the protection mechanism for peroxidases of PEG is based in its antioxidant capacity with which it is able scavenge or drain radicals that are harmful to the protein.

Entities:  

Keywords:  Antioxidant; PEG; Peroxidase; Poly(ethylene glycol); Stability

Mesh:

Substances:

Year:  2015        PMID: 26306530     DOI: 10.1007/s12010-015-1820-y

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  5 in total

1.  Preliminary Findings on the Effect of Ultrasmall Superparamagnetic Iron Oxide Nanoparticles and Acute Stress on Selected Markers of Oxidative Stress in Normotensive and Hypertensive Rats.

Authors:  Lucia Laubertova; Monika Dvorakova; Peter Balis; Angelika Puzserova; Ingrid Zitnanova; Iveta Bernatova
Journal:  Antioxidants (Basel)       Date:  2022-04-09

2.  Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin.

Authors:  Pamela S Hair; Kenji M Cunnion; Neel K Krishna
Journal:  Int J Pept       Date:  2017-09-10

3.  Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).

Authors:  Monika Yadav; Nicola Schiavone; Ana Guzman-Aranguez; Fabrizio Giansanti; Laura Papucci; Maria J Perez de Lara; Mandeep Singh; Indu Pal Kaur
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 4.617

Review 4.  Nanoantioxidants: Pioneer Types, Advantages, Limitations, and Future Insights.

Authors:  Basma Omran; Kwang-Hyun Baek
Journal:  Molecules       Date:  2021-11-21       Impact factor: 4.411

5.  Antifibrotic preventive effect of polyethylene glycol (PEG) 3350 in methotrexateinduced hepatoxicity model.

Authors:  Hüseyin Acar; Omay Sorgun; Güner Yurtseve; Ejder Saylav Bora; Oytun Erbaş
Journal:  Acta Cir Bras       Date:  2022-07-22       Impact factor: 1.564

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.